Palatin Technologies
PTN
#10775
Rank
C$27.1 M
Marketcap
C$15.23
Share price
-18.11%
Change (1 day)
N/A
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -C$8.46 Million

According to Palatin Technologies's latest financial reports the company's current earnings are C$12.88 Million. In 2025 the company made an earning of -C$13.4 Million, an increase over its 2024 earnings that were of -C$37.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$8.46 Million-36.9%
2025 -C$13.4 Million-64.29%
2024 -C$37.51 Million-16.9%
2023 -C$45.14 Million5.99%
2022 -C$42.59 Million-13.7%
2021 -C$49.35 Million33.25%
2020 -C$37.03 Million-172.11%
2019 C$51.35 M2352.33%
2018 C$2.09 M-94.13%
2017 C$35.68 M-154.92%
2016 -C$64.97 Million3.67%
2015 -C$62.67 Million878%
2014 -C$6.41 Million-72.64%
2013 -C$23.43 Million-33.11%
2012 -C$35.02 Million77.71%
2011 -C$19.71 Million
2003 -C$33.37 Million29.93%
2002 -C$25.68 Million36.18%
2001 -C$18.86 Million
1999 -C$15.65 Million6.04%
1998 -C$14.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.17 B-416,306.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$20.41 B-235,029.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$1.11 B-12,897.47%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-C$16.31 Million 87.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$0.26 B-3,151.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-C$0.17 Billion 1,784.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
C$0.16 B-1,958.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-C$41.06 Million 372.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-C$80.68 Million 828.28%๐Ÿ‡บ๐Ÿ‡ธ USA